S&P adds AmSurg to mid-cap index

Surgery and physician services company AmSurg is moving up the ranks of Standard & Poor's. The stock index compilers on Wednesday said the Burton Hills-based company will jump from the SmallCap 600 to the MidCap 400 on the afternoon of Oct. 14. Shares of AmSurg (Ticker: AMSG) rose more than 1 percent after hours Wednesday, adding to the nearly 3 percent gain from the regular session. Year to date, they're up almost 50 percent.

Oct 8, 2015 7:24 AM

PhyMed adds M&A exec

SVP helped build Symbion, Vanguard networks
Sep 16, 2015 11:34 AM

Analyst action: Hospitals, AmSurg

Analyst Sarah James has formally begun covering shares of Nashville's big three hospital operators as well as other prominent health care players. She rates both HCA Holdings and Community Health Systems at 'outperform,' saying investors will benefit from, among other things, the growth of HCA's Parallon support services unit and CHS' potential for margin expansion. James isn't as bullish on the prospects of LifePoint Health, which she has given a 'neutral' rating.

Over at Goldman Sachs, analysts have launched coverage of Amsurg with a 'buy' rating and $81 target. That's 17 percent above where AmSurg (Ticker: AMSG) closed Wednesday trading.

Jun 11, 2015 7:39 AM

HCA acquires physician practice management company

California deal adds 800 physicians to company's network
Jun 2, 2015 12:30 PM

MDsave raises $14M

Nashville company plans to take consumer-facing marketplace national
May 13, 2015 10:43 AM

Newly formed hospital staffing company acquires two peers

Brentwood-based American Physician Partners already serving 23 hospitals
May 7, 2015 10:51 AM

Earnings wrap: CHS, AmSurg

Hospital owner reverses prior-year loss, surgery center operator raises guidance
May 6, 2015 6:52 AM

AmSurg acquires anesthesia practice

Buy is second in Florida after Sheridan integration
Apr 2, 2015 7:00 AM

Dickson Medical to pay $500K in False Claims settlement

Dickson Medical Associates will pay $500,000 in civil damages for distributing non-FDA approved drugs.

The U.S. Attorney for the Middle District of Tennessee alleges that a physician at Dickson Medical Associates obtained and prescribed non-FDA approved Aclasta from foreign sources and billed for it as Reclast, which is approved in the United States. The drugs are used to treat osteoporosis and bone damage.

"The Food, Drug and Cosmetic Act and its enacting regulations exist to ensure the safety and efficacy of prescription drugs sold within the United States," David Rivera, U.S. Attorney, said in a release. "The resolution set fourth in this settlement agreement should send a clear message that this office will diligently pursue any violations of those laws."

Feb 24, 2015 7:00 AM

New 5% owners for AmSurg, Kirkland's

Two Texas investment firms have declared sizable stakes in local companies. First up, Vaughan Nelson Investment Management of Houston added to its stake in AmSurg late in 2014, finishing the year with more than 2.2 million shares, or 5.9 percent. Vaughan Nelson manages more than $6.6 billion. AmSurg shares (Ticker: AMSG) finished last week at $55.56 and have climbed 11 percent over the past three months.

Further up Interstate 45 in Dallas, Nokomis Capital filed papers to say it now owns almost 1.2 million shares, or 6.8 percent, of home goods retailer Kirkland's. The hedge fund, which was launched in 2008, manages almost $400 million. Kirkland's has been on a good sales and profits run of late, with its shares (Ticker: KIRK) having climbed 35 percent over the past three months.

Feb 16, 2015 8:42 AM